Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Study on Hemodialysis: Illumination Effects" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Study on Hemodialysis: Illumination Effects for you to read. Along with our medical data and news we also list Study on Hemodialysis: Illumination Effects Clinical Trials, which are updated daily. BioPortfolio also has a large database of Study on Hemodialysis: Illumination Effects Companies for you to search.
In a new case study published in the Journal of Oral Implantology, researchers introduce a promising new method of dental reconstruction in treating a severely compromised mandible in a patient recovering from head and neck cancer. LAWRENCE, Kan. (PRWEB) November 13, 2018 Journal of Oral Implantology – Dental implants have become a reliable, long-term treatment option for restoring proper speec...
A new study by @LSHTM reinforces the success of integrated health services in increasing access to #familyplanning through our work w/ @CARE , @theIRC, @Save_Children & @WorldVisionUSA: https://on.pfizer.com/2DBpXCl #ICFP2018pic.twitter.com/s2OFsRRA1h
A new study by @LSHTM reinforces the success of integrated health services in increasing access to #familyplanning through our work w/ @CARE , @theIRC, @Save_Children & @WorldVisionUSA: https://on.pfizer.com/2DBpXCl
The uproar highlighted decades-old tension over an effective ban on federal research of the public health effects of gun violence.
A new study by faculty at the Keck Graduate Institute (KGI) School of Pharmacy and Health Sciences and collaborators with the UC San Francisco’s Department of Family and Community Medicine investigated California pharmacists’ furnishing of naloxone without a prescription two years after legislation was implemented. CLAREMONT, Calif. (PRWEB) November 13, 2018 A recent public health advisory fr...
(CNN) – The United States has more than double the rate of premature overdose deaths of at least 12 other countries, according to a new study. The research, published Monday in the Annals of Internal Medicine, says that there were … Read More
In general, NETs are considered an “immunological desert,” but a new study showed some promise for immunotherapy.
Nancy Nixon, MD, discusses the retrospective study of the evolution of biosimilars in oncology, with a focus on trastuzumab and the path toward the integration of biosimilars into cancer care.
Nightstar Therapeutics (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, provided an update on recent achievements and upcoming clinical milestones and reported financial results for the quarter ended September 30, 2018. As quoted in the press release: “We are pleased with the upcoming initiation of the Phase 2/3 expansion study ̷...
Read out, correct, repeat - a new study published in Nature tackles how to perform the repeated detection of errors and their correction in a quantum computation thanks to a dual-species register of three co-trapped ions. https://go.nature.com/2B1krGq p
Read out, correct, repeat - a new study published in Nature tackles how to perform the repeated detection of errors and their correction in a quantum computation thanks to a dual-species register of three co-trapped ions. https://go.nature.com/2B1krGq pic.twitter.com/CF2wVkFXbF
Defend Your Head, the sports safety company based in Chester Spring, Pennsylvania, is proud to announce promising results of an independent study recently released by Penn State University centered on football related head injuries. The three year study indicates that ProTech, the exclusive soft shell helmet technology developed by DYH, was a primary ...
(MedPage Today) -- Highlights from the Palliative and Supportive Care in Oncology Symposium
A leading researcher in breast cancer screening has questioned the validity of a new observational study from Sweden which found greater benefit with breast cancer treatment in women taking part in...
EXPEDITION-8 is the first Phase 3b study evaluating 8 weeks of MAVYRET™ in treatment-naïve chronic hepatitis C virus (HCV)-infected patients with compensated cirrhosis across all major genotypes (GT1-6)1 In cohort one, 100 percent of genotype 1, 2, 4, 5 and 6 treatment-naïve chronic HCV patients with compensated cirrhosis ...
Kits to self-test for human papillomavirus (HPV) mailed to underserved women helped to identify virtually all of those with high-risk HPV oncogenic types, in a proof-of-principle study. Medscape Medical News
SummaryAxoGen Inc AxoGen, formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch twopoint discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among others. It also offers clinical research studies in understanding and outcome of peripheral nerve regen...
1. Pharmacist-led education resulted in greater discontinuation of sedative-hypnotic drugs compared to care as usual. Evidence Rating Level: 1 (Excellent) Study Rundown: Inappropriate prescribing of medications such as benzodiazepines, antihistamines, and anti-inflammatory drugs for older adults can lead to adverse events and hospitalization. Targeted educational efforts to deprescribe thes...
A genomic study conducted by the University of Exeter, UK, and the University of South Australia has found that higher...Read More... The post Genomic study directly links depression to obesity appeared first on Pharmaceutical Technology.
(MedPage Today) -- Study shows high response rate even with imperfect adherence
1. The findings of this study suggested that cancer is becoming the leading cause of death in the United States among higher-income counties. 2. The authors observed that lower-income counties were more likely to have heart disease as the leading cause of death. Evidence Rating Level: 2 (Good) Study Rundown: The epidemiologic transition theory describes […]
Vitamin D did not prevent adverse cardiovascular events or cancer in a large randomized trial.
Supplements did not lower the overall incidence of adverse cardiovascular events in a large randomized trial.
(MedPage Today) -- Small phase II study also found reductions in liver fat vs placebo
NewsEmpagliflozin has important effects that can improve cardiac structure in people with Type 2 diabetes who also have heart disease.Contributed A
A study in Thyroid evaluated the safety and efficacy of concurrent intensity-modulated radiation therapy and doxorubicin in thyroid cancer.